Identifying the worst of the worst: HER2 positive early stage uterine papillary serous carcinoma.

Identifying the worst of the worst: HER2 positive early stage uterine papillary serous carcinoma. Gynecol Oncol. 2020 Oct;159(1):1-2 Authors: Rossi EC PMID: 33008583 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33008583?dopt=Abstract

Source: Gynecologic Oncology - September 30, 2020 Category: Cancer & Oncology Authors: Rossi EC Tags: Gynecol Oncol Source Type: research

More News: Cancer & Oncology | Carcinoma | Endometrial Cancer | HER2 | Serous Carcinoma